Machine learning framework to predict pharmacokinetic profile of small molecule drugs based on chemical structure
Clinical and Translational Science · 2024-05 · 17 (5)
DOI: 10.1111/cts.13824 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 16.05.2024. Verfasst von Nikhil Pillai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Global DMPK Modeling & Simulation, Sanofi, Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: Machine Learning, Drug Discovery. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Accurate prediction of a new compound's pharmacokinetic (PK) profile is pivotal for the success of drug discovery programs. An initial assessment of PK in preclinical species and humans is typically performed through allometric scaling and mathematical modeling. These methods use parameters estimated from in vitro or in vivo experiments, which although helpful for an initial estimation, require extensive animal experiments. Furthermore, mathematical models are limited by the mechanistic underpinning of the drugs' absorption, distribution, metabolism, and elimination (ADME) which are largely unknown in the early stages of drug discovery. In this work, we propose a novel methodology in which concentration versus time profile of small molecules in rats is directly predicted by machine learning (ML) using structure‐driven molecular properties as input and thus mitigating the need for animal experimentation. The proposed framework initially predicts ADME properties based on molecular structure and then uses them as input to a ML model to predict the PK profile. For the compounds tested, our results demonstrate that PK profiles can be adequately predicted using the proposed algorithm, especially for compounds with Tanimoto score greater than 0.5, the average mean absolute percentage error between predicted PK profile and observed PK profile data was found to be less than 150%. The suggested framework aims to facilitate PK predictions and thus support molecular screening and design earlier in the drug discovery process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Global DMPK Modeling & Simulation, Sanofi, Cambridge, Massachusetts, USA.
- Commercial Data and Analytics, Sanofi, Barcelona, Spain.
- Translational Medicine & Early Development, Sanofi, Vitry-sur-Seine, France.
ORCID-Profile: Nikhil Pillai, Panteleimon D Mavroudis
Zitieren
APA
Pillai, N., Abos, A., Teutonico, D., & Mavroudis, P. D. (2024). Machine learning framework to predict pharmacokinetic profile of small molecule drugs based on chemical structure. Clinical and Translational Science, 17(5). https://doi.org/10.1111/cts.13824
Vancouver
Pillai N, Abos A, Teutonico D, Mavroudis PD. Machine learning framework to predict pharmacokinetic profile of small molecule drugs based on chemical structure. Clinical and Translational Science. 2024;17(5). doi:10.1111/cts.13824
BibTeX
@article{Pillai2024,
author = {Pillai, Nikhil and Abos, Alexandra and Teutonico, Donato and Mavroudis, Panteleimon D},
title = {Machine learning framework to predict pharmacokinetic profile of small molecule drugs based on chemical structure},
journal = {Clinical and Translational Science},
year = {2024},
volume = {17},
number = {5},
doi = {10.1111/cts.13824}
}
EUVIMED